\-\ Texto\\:\\ \ \(0\)\
\-\ chemotherapy\\ and\\ radiation\ \(25\)\
\-\ subtotal\\ destruction\\ of\\ the\\ right\\ ischium\\.\ \(0\)\
\-\ skeletal\\ metastasis\\.\ \(0\)\
\-\ skeletal\\ metastasis\ \(0\)\
\-\ primary\\ bone\\ tumor\\ \\(e\\.g\\.\\ lymphoma\\)\ \(0\)\
\-\ infection\ \(713\)\
\-\ 57\\ year\\ old\\ male\\ has\\ right\\ hip\\ pain\\.\ \(1\)\
\-\ given\\ the\\ relative\\ frequency\\,\\ metastatic\\ lesion\\ is\\ most\\ likely\\.\\ \\ the\\ patient\\ had\\ no\\ known\\ malignancy\\ at\\ the\\ time\\ of\\ this\\ study\\.\ \(0\)\
\-\ primary\\ aggressive\\ tumor\\ of\\ bone\\ is\\ possible\\,\\ although\\ less\\ likely\\ given\\ relative\\ frequency\\.\ \(0\)\
\-\ infection\\ is\\ possible\\,\\ although\\ would\\ expect\\ more\\ perilesional\\ osteoporosis\\ and\\ joint\\ involvement\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ frequency\\:\\ 0\\.10491751932005414\ \(0\)\
\-\ skeletal\\:\\ 0\\.09814880404260252\ \(0\)\
\-\ relative\\:\\ 0\\.09466479757216856\ \(0\)\
\-\ ischium\\:\\ 0\\.08973146668951615\ \(0\)\
\-\ perilesional\\:\\ 0\\.07462352501358288\ \(0\)\
\-\ metastasis\\:\\ 0\\.07438947270464946\ \(0\)\
\-\ subtotal\\:\\ 0\\.07268103565703443\ \(0\)\
\-\ given\\:\\ 0\\.06812591610503121\ \(0\)\
\-\ although\\:\\ 0\\.06711463443201404\ \(0\)\
\-\ possible\\:\\ 0\\.06692981904381563\ \(0\)\
\-\ expect\\:\\ 0\\.06604679311671335\ \(0\)\
\-\ osteoporosis\\:\\ 0\\.060208514700466426\ \(0\)\
\-\ primary\\:\\ 0\\.05886940146269061\ \(0\)\
\-\ infection\\:\\ 0\\.05776782730401877\ \(0\)\
\-\ likely\\:\\ 0\\.05605325502175945\ \(0\)\
\-\ 57\\:\\ 0\\.05414692256519565\ \(0\)\
\-\ e\\.g\\:\\ 0\\.05261696491648962\ \(0\)\
\-\ bone\\:\\ 0\\.04938220189441558\ \(0\)\
\-\ destruction\\:\\ 0\\.04907440202130126\ \(0\)\
\-\ aggressive\\:\\ 0\\.048613830648103054\ \(0\)\
\-\ tumor\\:\\ 0\\.04633098375839096\ \(0\)\
\-\ hip\\:\\ 0\\.03957991130362161\ \(0\)\
\-\ malignancy\\:\\ 0\\.038396391602343205\ \(0\)\
\-\ involvement\\:\\ 0\\.0364178913561374\ \(0\)\
\-\ chemotherapy\\:\\ 0\\.035615648664428665\ \(0\)\
\-\ would\\:\\ 0\\.03536007998165221\ \(0\)\
\-\ less\\:\\ 0\\.03365046516654282\ \(0\)\
\-\ study\\:\\ 0\\.03269338787046464\ \(0\)\
\-\ radiation\\:\\ 0\\.032607572669329496\ \(0\)\
\-\ joint\\:\\ 0\\.032132898314442805\ \(0\)\
\-\ known\\:\\ 0\\.03144245447050953\ \(0\)\
\-\ lymphoma\\:\\ 0\\.028397658539412625\ \(0\)\
\-\ time\\:\\ 0\\.028065130549294333\ \(0\)\
\-\ metastatic\\:\\ 0\\.02501290004204756\ \(0\)\
\-\ more\\:\\ 0\\.02485088731758333\ \(0\)\
\-\ most\\:\\ 0\\.022939943508466\ \(0\)\
\-\ had\\:\\ 0\\.02144011417721754\ \(0\)\
\-\ right\\:\\ 0\\.020968179281637595\ \(0\)\
\-\ lesion\\:\\ 0\\.02023901425581924\ \(0\)\
\-\ is\\:\\ 0\\.01961479459481601\ \(0\)\
\-\ has\\:\\ 0\\.018659301982491605\ \(0\)\
\-\ male\\:\\ 0\\.0179675062545055\ \(0\)\
\-\ at\\:\\ 0\\.01346236224222829\ \(0\)\
\-\ pain\\:\\ 0\\.012134978692217845\ \(0\)\
\-\ this\\:\\ 0\\.011176014108303873\ \(0\)\
\-\ year\\:\\ 0\\.011117503131080404\ \(0\)\
\-\ old\\:\\ 0\\.010173658103049472\ \(0\)\
\-\ no\\:\\ 0\\.010005164543067465\ \(0\)\
\-\ patient\\:\\ 0\\.00996037128972544\ \(0\)\
\-\ \\,\\:\\ 0\\.009443374378510025\ \(0\)\
\-\ \\(\\:\\ 0\\.00839955495632396\ \(0\)\
\-\ \\)\\:\\ 0\\.008296949908294245\ \(0\)\
\-\ the\\:\\ 0\\.006430199288540735\ \(0\)\
\-\ and\\:\\ 0\\.0041862559472608946\ \(0\)\
\-\ of\\:\\ 0\\.004064086074348433\ \(0\)\
\-\ \\.\\:\\ 0\\.0033022824276601184\ \(0\)\
